| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |